Again.... it’s up to Yoram now...
don’t be surprised with a few weeks of quiet
which means stock could possibly drop a bit
more...
but I would expect a nice “jerk” upward at the
Virucure, ticker change date along with
date of split....
then, hopefully announcements...
- clinical trials
- funding
- partnerships.....
only strong announcements can sustain $25,
$35, $45 share price....
And the only good news for today is that with the
reduction of A\S also.... non-dilution funding is
Already in place
Good luck to all